Barrett Adenocarcinoma
8
0
0
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
1 terminated out of 8 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Aceto-whitening in the Assessment of Gastrointestinal Neoplasia
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
Neoplastic Barrett Esophagus: Endoscopic Piecemeal vs. En Bloc Resection
Public's Intended Uptake and Views on Organization of Esophageal Cancer Screening
Endoscopic Mucosal Resection and Cellular Matrix
Real-time Computer Aided Detection of Barrett's Neoplasia
EMR Versus ESD for Barrett's Neoplasia
ESD Versus EMR for Treatment of Early Barrett's Adenocarcinoma